in-stent restenosis drug-eluting balloon everolimus-eluting stent optical coherence tomography Abstract
Background: The optimal treatment of bare metal stent restenosis is still not defined. The most employed contemporary option is the implantation of a drug-eluting stent (DES). However, this procedure implies the addition of a second metal layer in the vessel wall, which is linked to delayed healing. Furthermore, there may be a increased risk of malapposition of both struts of the bare metal and the newly implanted drug-eluting stent. These phenomena may give rise to an increased risk of stent thrombosis in this patient population. Recently, drug-eluting balloons (DEB) ...
Sign in to read and download the full articleForgot your password?
No account yet? Sign up for free!Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
in-stent restenosisdrug-eluting ballooneverolimus-eluting stentoptical coherence tomography
Read next articleAntiplatelet therapy in the era of percutaneous coronary intervention with drug-eluting balloons